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Figure 4. Antimutagenic effects of (A) bilirubin (1), bilirubin ditaurate (2), bilirubin dimethyl ester (3); (B) biliverdin (4), biliverdin dimethyl ester (5); and (C) stercobilin (6), urobilin (7), and protoporphyrin (8) against metabolically activated 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP, 10; 0.1 × 10 −7 mol/plate)-induced mutagenesis in Salmonella typhimurium strain TA98. Figure 3 . Antimutagenic effects of (A) bilirubin (1), bilirubin ditaurate (2), bilirubin dimethyl ester (3); (B) biliverdin (4), biliverdin dimethyl ester (5); and (C) stercobilin (6), urobilin (7), and protoporphyrin (8) against metabolically activated aflatoxin B1 (AfB1, 9; 0.8 × 10 −7 mol/plate)-induced mutagenesis in Salmonella typhimurium strain TA98.
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